Qin Yali, Yuan Wei, Deng Hui, Xiang Zhanmei, Yang Chao, Kou Xinyun, Yang Shufei, Wang Zhijun, Jin Ming
Department of Ophthalmology, China-Japan Friendship Hospital, No. 2, East Yinghua Street, Chaoyang, Beijing 100029, China ; Beijing University of Chinese Medicine, Beijing 100029, China.
Department of Ophthalmology, China-Japan Friendship Hospital, No. 2, East Yinghua Street, Chaoyang, Beijing 100029, China.
Evid Based Complement Alternat Med. 2015;2015:713218. doi: 10.1155/2015/713218. Epub 2015 May 24.
Objective. To determine whether acupuncture treatment impacts the clinical efficacy of degenerative damage of the optic nerve caused by nonarteritic anterior ischemic optic neuropathy (NAION). Methods. 69 patients (93 eyes) with NAION who had been treated by acupuncture which is performed on different acupoints related to eyes by vertical insertion or Fingernail-pressure needle insertion. The best corrected visual acuity, mean defect (MD) and mean light sensitivity (MS) of the visual field, and latency and amplitude of pattern visual evoked potential (P-VEP) were compared before and after treatment. Results. After 2, 4, and 8 weeks of treatment, the total effective rates of visual acuity improvement were 74.19%, 78.89%, and 81.71%, respectively, and the decreased MD and increased MS were both statistically significant (P < 0.01). When compared with the situation before treatment, the average latency of the P100 wave was significantly reduced (P < 0.05), and the average amplitude was improved with no statistically significant difference (P > 0.05). Conclusions. Acupuncture treatment could obviously improve the visual function of patients with NAION and be used as complementary and alternative therapy in clinic.
目的。确定针刺治疗是否会影响非动脉炎性前部缺血性视神经病变（NAION）所致视神经退行性损害的临床疗效。方法。69例（93只眼）NAION患者接受针刺治疗，针刺通过垂直进针或指压进针施于与眼睛相关的不同穴位。比较治疗前后的最佳矫正视力、视野平均缺损（MD）和平均光敏感度（MS），以及图形视觉诱发电位（P-VEP）的潜伏期和波幅。结果。治疗2、4和8周后，视力改善的总有效率分别为74.19%、78.89%和81.71%，MD降低和MS升高均有统计学意义（P<0.01）。与治疗前相比，P100波的平均潜伏期显著缩短（P<0.05），平均波幅有所改善，但无统计学意义（P>0.05）。结论。针刺治疗可明显改善NAION患者的视功能，可作为临床上的补充和替代疗法。
